Origin Enterprises Valuation
Is OGN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
6/6Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of OGN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: OGN (€3.05) is trading below our estimate of fair value (€11.01)
Significantly Below Fair Value: OGN is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for OGN?
Key metric: As OGN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is OGN's PE Ratio? | |
|---|---|
| PE Ratio | 7.8x |
| Earnings | €40.43m |
| Market Cap | €316.12m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.2x |
| Enterprise Value/EBITDA | 5.1x |
| PEG Ratio | 0.5x |
Price to Earnings Ratio vs Peers
How does OGN's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 8.1x | ||
AEP Anglo-Eastern Plantations | 6.3x | n/a | UK£274.8m |
MPE M.P. Evans Group | 10x | 1.2% | UK£519.2m |
WYN Wynnstay Group | 12x | n/a | UK£70.9m |
MHPC MHP | 3.9x | n/a | US$446.3m |
OGN Origin Enterprises | 7.8x | 16.5% | €316.1m |
Price-To-Earnings vs Peers: OGN is good value based on its Price-To-Earnings Ratio (7.8x) compared to the peer average (8.1x).
Price to Earnings Ratio vs Industry
How does OGN's PE Ratio compare vs other companies in the European Food Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: OGN is good value based on its Price-To-Earnings Ratio (7.8x) compared to the European Food industry average (13.5x).
Price to Earnings Ratio vs Fair Ratio
What is OGN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 7.8x |
| Fair PE Ratio | 16.7x |
Price-To-Earnings vs Fair Ratio: OGN is good value based on its Price-To-Earnings Ratio (7.8x) compared to the estimated Fair Price-To-Earnings Ratio (16.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €3.05 | €4.87 +59.7% | 7.9% | €5.40 | €4.30 | n/a | 5 |
| Nov ’25 | €3.20 | €4.87 +52.2% | 7.9% | €5.40 | €4.30 | n/a | 5 |
| Oct ’25 | €3.40 | €4.87 +43.2% | 7.9% | €5.40 | €4.30 | n/a | 5 |
| Sep ’25 | €3.25 | €5.14 +58.1% | 7.6% | €5.60 | €4.60 | n/a | 4 |
| Aug ’25 | €3.10 | €5.14 +65.7% | 7.6% | €5.60 | €4.60 | n/a | 4 |
| Jul ’25 | €3.20 | €5.14 +60.5% | 7.6% | €5.60 | €4.60 | n/a | 4 |
| Jun ’25 | €3.11 | €5.14 +65.2% | 7.6% | €5.60 | €4.60 | n/a | 4 |
| May ’25 | €3.30 | €4.95 +50.0% | 11.6% | €5.60 | €4.20 | n/a | 4 |
| Apr ’25 | €3.10 | €4.66 +50.2% | 17.3% | €5.60 | €3.19 | n/a | 6 |
| Mar ’25 | €3.26 | €4.85 +48.7% | 16.9% | €5.60 | €3.19 | n/a | 6 |
| Feb ’25 | €3.40 | €4.85 +42.6% | 16.9% | €5.60 | €3.19 | n/a | 6 |
| Jan ’25 | €3.50 | €4.85 +38.5% | 16.9% | €5.60 | €3.19 | n/a | 6 |
| Dec ’24 | €3.50 | €4.85 +38.5% | 16.9% | €5.60 | €3.19 | n/a | 6 |
| Nov ’24 | €3.20 | €4.85 +51.5% | 16.9% | €5.60 | €3.19 | €3.20 | 6 |
| Oct ’24 | €3.27 | €4.85 +48.3% | 16.9% | €5.60 | €3.19 | €3.40 | 6 |
| Sep ’24 | €3.30 | €5.20 +57.6% | 8.8% | €5.90 | €4.60 | €3.25 | 5 |
| Aug ’24 | €3.23 | €5.20 +61.0% | 8.8% | €5.90 | €4.60 | €3.10 | 5 |
| Jul ’24 | €3.30 | €5.20 +57.6% | 8.8% | €5.90 | €4.60 | €3.20 | 5 |
| Jun ’24 | €3.45 | €5.35 +55.1% | 7.2% | €5.90 | €4.90 | €3.11 | 4 |
| May ’24 | €4.05 | €5.50 +35.8% | 5.9% | €5.90 | €5.10 | €3.30 | 3 |
| Apr ’24 | €4.25 | €5.50 +29.4% | 5.9% | €5.90 | €5.10 | €3.10 | 3 |
| Mar ’24 | €4.25 | €5.31 +24.9% | 8.2% | €5.90 | €4.73 | €3.26 | 4 |
| Feb ’24 | €4.25 | €5.16 +21.4% | 5.5% | €5.50 | €4.73 | €3.40 | 4 |
| Jan ’24 | €4.35 | €5.16 +18.6% | 5.5% | €5.50 | €4.73 | €3.50 | 4 |
| Dec ’23 | €3.95 | €5.16 +30.6% | 5.5% | €5.50 | €4.73 | €3.50 | 4 |
| Nov ’23 | €3.65 | €5.16 +41.3% | 5.5% | €5.50 | €4.73 | €3.20 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Bakkavor Group
UK£751.9m
Engages in the preparation and marketing of fresh prepared foods in the United Kingdom, the United States, and China.
BAKKL
UK£1.30
7D
-3.7%
1Y
52.0%
Ebro Foods
€2.4b
Operates as a food company in Spain, rest of Europe, the United States, Canada, and internationally.
0NYH
€15.74
7D
-2.2%
1Y
0.6%
M.P. Evans Group
UK£519.2m
Through its subsidiaries, engages in the ownership and development of oil palm plantations in Indonesia and Malaysia.
MPE
UK£9.90
7D
6.0%
1Y
34.5%